BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hagymási K, Tulassay Z. Helicobacter pylori infection: New pathogenetic and clinical aspects. World J Gastroenterol 2014; 20(21): 6386-6399 [PMID: 24914360 DOI: 10.3748/wjg.v20.i21.6386] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin HC, Hsu HY, Lin HL, Uang YS, Ho Y, Wang LH. Association Between Acid-Suppressive Agents’ Use and Risk of Hepatocellular Carcinoma. Dose-Response 2020;18:155932582090753. [DOI: 10.1177/1559325820907530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Erriu M, Pili FM, Cadoni S, Garau V. Diagnosis of Lingual Atrophic Conditions: Associations with Local and Systemic Factors. A Descriptive Review. Open Dent J 2016;10:619-35. [PMID: 27990187 DOI: 10.2174/1874210601610010619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Abdel-Moein KA, Saeed H, Samir A. Novel detection of Helicobacter pylori in fish: A possible public health concern. Acta Trop. 2015;152:141-144. [PMID: 26364719 DOI: 10.1016/j.actatropica.2015.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Abu-Taleb AMF, Abdelattef RS, Abdel-Hady AA, Omran FH, El-Korashi LA, Abdel-Aziz El-Hady H, El-Gebaly AM. Prevalence of Helicobacter pylori cagA and iceA Genes and Their Association with Gastrointestinal Diseases. Int J Microbiol. 2018;2018:4809093. [PMID: 29849647 DOI: 10.1155/2018/4809093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
5 Lin S, Zhang Y, Hu Y, Yang B, Cui J, Huang J, Wang JM, Xing R, Lu Y. Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-κB-mediated expression of CEACAM1-3S in human gastric cancer. Gastric Cancer 2019;22:941-54. [PMID: 30778796 DOI: 10.1007/s10120-019-00932-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Talebi Bezmin Abadi A. Vaccine against Helicobacter pylori: Inevitable approach. World J Gastroenterol 2016; 22(11): 3150-3157 [PMID: 27003991 DOI: 10.3748/wjg.v22.i11.3150] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
7 Siupsinskiene N, Katutiene I, Jonikiene V, Janciauskas D, Vaitkus S. Intranasal Helicobacter pylori infection in patients with chronic rhinosinusitis with polyposis. J Laryngol Otol 2018;132:816-21. [DOI: 10.1017/s0022215118001299] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Wang X, Yung MMH, Sharma R, Chen F, Poon YT, Lam WY, Li B, Ngan HYS, Chan KKL, Chan DW. Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis. Cancers (Basel) 2021;13:4795. [PMID: 34638280 DOI: 10.3390/cancers13194795] [Reference Citation Analysis]
9 Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep 2015;5:14554. [PMID: 26416623 DOI: 10.1038/srep14554] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 12.4] [Reference Citation Analysis]
10 Tharmalingam N, Port J, Castillo D, Mylonakis E. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori. Sci Rep 2018;8:3701. [PMID: 29487357 DOI: 10.1038/s41598-018-22037-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 11.8] [Reference Citation Analysis]
11 Galal AMF, Mohamed HS, Abdel-Aziz MM, Hanna AG. Development, synthesis, and biological evaluation of sulfonyl-α-l-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors. Arch Pharm (Weinheim) 2021;354:e2000385. [PMID: 33576040 DOI: 10.1002/ardp.202000385] [Reference Citation Analysis]
12 Arora N, Majumder K, Gupta A. Gastric cancer and the microbiome. Asian Pacific Journal of Tropical Disease 2015;5:353-7. [DOI: 10.1016/s2222-1808(14)60796-9] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Nam S, Kim JH, Lee DH. RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential. Front Genet 2019;10:438. [PMID: 31156701 DOI: 10.3389/fgene.2019.00438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
14 Beeby M. Motility in the epsilon-proteobacteria. Current Opinion in Microbiology 2015;28:115-21. [DOI: 10.1016/j.mib.2015.09.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
15 Andersen MF, Bygum A. Idiopathic Thrombocytopenic Purpura Misdiagnosed as Hereditary Angioedema. Case Rep Dermatol Med 2015;2015:934247. [PMID: 26819784 DOI: 10.1155/2015/934247] [Reference Citation Analysis]
16 Fahimi F, Tohidkia MR, Fouladi M, Aghabeygi R, Samadi N, Omidi Y. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. Bioimpacts 2017;7:59-71. [PMID: 28546954 DOI: 10.15171/bi.2017.08] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
17 Buzás GM. [Helicobacter pylori -- 2014]. Orv Hetil 2015;156:203-10. [PMID: 25639633 DOI: 10.1556/OH.2015.30097] [Reference Citation Analysis]
18 Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter 2015;20:239-51. [PMID: 25728540 DOI: 10.1111/hel.12200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
19 Fahimi F, Sarhaddi S, Fouladi M, Samadi N, Sadeghi J, Golchin A, Tohidkia MR, Barar J, Omidi Y. Phage display-derived antibody fragments against conserved regions of VacA toxin of Helicobacter pylori. Appl Microbiol Biotechnol 2018;102:6899-913. [PMID: 29862446 DOI: 10.1007/s00253-018-9068-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
20 Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol 2017; 23(9): 1521-1540 [PMID: 28321154 DOI: 10.3748/wjg.v23.i9.1521] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
21 Fernandes YC, Bonatto Gda R, Bonatto MW. Recurrence rate of Helicobacter pylori in patients with peptic ulcer five years or more after successful eradication. Arq Gastroenterol. 2016;53:152-155. [PMID: 27438419 DOI: 10.1590/s0004-28032016000300006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Maev IV, Andreev DN, Kucheryavyi YA. [Helicobacter pylori infection and extragastroduodenal diseases]. Ter Arkh 2015;87:103-10. [PMID: 28635878 DOI: 10.17116/terarkh2015878103-110] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta-analysis. Int Urol Nephrol 2019;51:1361-70. [PMID: 31214954 DOI: 10.1007/s11255-019-02205-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Shah CP, Purushothaman G, Thiruvenkatam V, Kirubakaran S, Juvale K, Kharkar PS. Design, synthesis and biological evaluation of Helicobacter pylori inosine 5′-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2. Bioorganic Chemistry 2019;87:753-64. [DOI: 10.1016/j.bioorg.2019.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Buzás GM. Fate of meta-analyses: The case of Helicobacter pyloriWorld J Meta-Anal 2015; 3(1): 20-25 [DOI: 10.13105/wjma.v3.i1.20] [Reference Citation Analysis]
27 Liu Q, Li X, Zhang Y, Song Z, Li R, Ruan H, Huang X. Orally-administered outer-membrane vesicles from Helicobacter pylori reduce H. pylori infection via Th2-biased immune responses in mice. Pathog Dis 2019;77:ftz050. [PMID: 31504509 DOI: 10.1093/femspd/ftz050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]